Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disks large-associated protein 4 (DLGAP4) is a synaptic scaffold protein found at the postsynaptic density of neurons, where it interacts with signaling molecules, potassium channels, and major synapse organizers such as PSD-95[3]. It is a member of the membrane-associated guanylate kinase (MAGUK) family and plays vital roles in the molecular organization of synapses, neuronal signal transduction, and regulation of the actin cytoskeleton[1][2]. DLGAP4 is essential for proper neuronal migration and cortical development, interacting with proteins involved in adherens junctions and actin dynamics[1]. Mutations in DLGAP4 are associated with neurological disorders including epilepsy, intellectual disability, schizophrenia, and others, and aberrant expression is linked to tumor progression and prognosis in hepatocellular carcinoma[1][4]. No approved drugs are known to directly target DLGAP4, but it may serve as a biomarker in some disease contexts[4].
Not applicable (no direct targeting drugs known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disks large-associated protein 4 (DLGAP4).